C

Cyclerion Therapeutics
D

CYCN

1.73000
USD
-0.04
(-2.26%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
4,352,462
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APTO
    -0.03680
    (-6.57%)
    0.52320 USD
    A
    ARLO
    -0.590
    (-3.89%)
    14.590 USD
    C
    CRVS
    0.36000
    (13.85%)
    2.96000 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    E
    EOLS
    1.660
    (13.38%)
    14.070 USD
    F
    FUTU
    -3.650
    (-5.77%)
    59.630 USD
    K
    KPTI
    -0.06290
    (-6.37%)
    0.92380 USD
    N
    NKTX
    -0.03000
    (-0.47%)
    6.41000 USD
    P
    PRVB
    -0.075
    (-0.31%)
    23.870 USD
    المزيد
الأخبار
المقالات

العنوان: Cyclerion Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.